BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17125178)

  • 1. The impact of tautomer forms on pharmacophore-based virtual screening.
    Oellien F; Cramer J; Beyer C; Ihlenfeldt WD; Selzer PM
    J Chem Inf Model; 2006; 46(6):2342-54. PubMed ID: 17125178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore-based virtual screening.
    Horvath D
    Methods Mol Biol; 2011; 672():261-98. PubMed ID: 20838973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tautomer preference in PDB complexes and its impact on structure-based drug discovery.
    Milletti F; Vulpetti A
    J Chem Inf Model; 2010 Jun; 50(6):1062-74. PubMed ID: 20515065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
    Krovat EM; Frühwirth KH; Langer T
    J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tautomer enumeration and stability prediction for virtual screening on large chemical databases.
    Milletti F; Storchi L; Sforna G; Cross S; Cruciani G
    J Chem Inf Model; 2009 Jan; 49(1):68-75. PubMed ID: 19123923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening.
    Kalliokoski T; Salo HS; Lahtela-Kakkonen M; Poso A
    J Chem Inf Model; 2009 Dec; 49(12):2742-8. PubMed ID: 19928753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.
    Wolber G; Langer T
    J Chem Inf Model; 2005; 45(1):160-9. PubMed ID: 15667141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
    Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
    J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2.
    Zou J; Xie HZ; Yang SY; Chen JJ; Ren JX; Wei YQ
    J Mol Graph Model; 2008 Nov; 27(4):430-8. PubMed ID: 18786843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fuzzy tricentric pharmacophore fingerprints. 1. Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes.
    Bonachéra F; Parent B; Barbosa F; Froloff N; Horvath D
    J Chem Inf Model; 2006; 46(6):2457-77. PubMed ID: 17125187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIPALSTREE: a new hierarchical clustering approach for large compound libraries and its application to virtual screening.
    Böcker A; Schneider G; Teckentrup A
    J Chem Inf Model; 2006; 46(6):2220-9. PubMed ID: 17125166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient in silico screening method based on the protein-compound affinity matrix and its application to the design of a focused library for cytochrome P450 (CYP) ligands.
    Fukunishi Y; Hojo S; Nakamura H
    J Chem Inf Model; 2006; 46(6):2610-22. PubMed ID: 17125201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning from the data: mining of large high-throughput screening databases.
    Yan SF; King FJ; He Y; Caldwell JS; Zhou Y
    J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of self-organizing neural networks in virtual screening and diversity selection.
    Selzer P; Ertl P
    J Chem Inf Model; 2006; 46(6):2319-23. PubMed ID: 17125175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of conformational flexibility on three-dimensional similarity searching using correlation vectors.
    Renner S; Schwab CH; Gasteiger J; Schneider G
    J Chem Inf Model; 2006; 46(6):2324-32. PubMed ID: 17125176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques.
    Ebalunode JO; Ouyang Z; Liang J; Zheng W
    J Chem Inf Model; 2008 Apr; 48(4):889-901. PubMed ID: 18396858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical assessment of the automated AutoDock as a new docking tool for virtual screening.
    Park H; Lee J; Lee S
    Proteins; 2006 Nov; 65(3):549-54. PubMed ID: 16988956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for generating less toxic P-selectin inhibitors: pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits.
    Ananthula RS; Ravikumar M; Pramod AB; Madala KK; Mahmood SK
    J Mol Graph Model; 2008 Nov; 27(4):546-57. PubMed ID: 18993099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.